Clincosm LogoSign in Get a demo

Hypercholesterolemia

Showing 51 - 75 of 690
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Hypertension, Hypercholesterolemia Trial in ShenZhen (Dengzhanxixin Capsule plus Placebo Capsule, Placebo)

Not yet recruiting
  • Diabetes
  • +2 more
  • Dengzhanxixin Capsule plus Placebo Capsule
  • Placebo
  • ShenZhen, ShenZhen, China
    Fuwai Hospital, Chinese Academy of Medical Sciences, Shenzhen
Jul 12, 2022

Dyslipidemias, High Cholesterol, Hypercholesterolemia Trial in United States (Obicetrapib, Ezetimibe 10mg, Obicetrapib )

Active, not recruiting
  • Dyslipidemias
  • +2 more
  • Gardena, California
  • +6 more
Jul 14, 2022

Hypercholesterolemia, Cardiovascular Diseases Trial in Cincinnati (lerodalcibep, evolocumab, alirocumab)

Active, not recruiting
  • Hypercholesterolemia
  • Cardiovascular Diseases
  • lerodalcibep
  • +2 more
  • Cincinnati, Ohio
  • +2 more
Jul 13, 2022

Hypercholesterolemia Trial in Cincinnati (lerodalcibep)

Completed
  • Hypercholesterolemia
  • Cincinnati, Ohio
    Metabolic & Atherosclerosis Research Center (MARC)
Jul 13, 2022

German Inclisiran Network: Retrospective Registry of Patients

Recruiting
  • Hypercholesterolemia
    • Jena, Germany
      Jena University Hospital
    Jul 4, 2022

    Efficacy of Treatment With PCSK9 Inhibitors in Italy

    Completed
    • Hypercholesterolemia
    • Repatha (evolocumab); Praluent (alirocumab)
    • Bari, Italy
    • +8 more
    Jun 20, 2022

    Hypercholesterolemia Trial in China (Rosuvastatin, SPC ezetimibe/rosuvastatin, Rosuvastatin active capsule)

    Completed
    • Hypercholesterolemia
    • Baotou, China
    • +39 more
    Jun 22, 2022

    Coronary Artery Disease, Bypass Graft Stenosis, Dyslipidemias Trial (Computed tomography coronary angiogram)

    Not yet recruiting
    • Coronary Artery Disease
    • +7 more
    • Computed tomography coronary angiogram
    • (no location specified)
    May 24, 2022

    Ezetimibe-Rosuvastatin Evaluation Study

    Not yet recruiting
    • Hypercholesterolemia
    • +2 more
      • Athens, Greece
        Athens University Hospital
      May 19, 2022

      Hypercholesterolemia, Hyperlipidemia Trial in Beijing (SHR-1209 ;)

      Active, not recruiting
      • Hypercholesterolemia
      • Hyperlipidemia
      • SHR-1209 ;placebo
      • Beijing, Beijing, China
        Beijing Anzhen Hospital, Capital Medical University
      May 23, 2022

      Overweight and Obesity, Hypercholesterolemia, Hypertriglyceridemia Trial in Murcia (Silibinin A)

      Active, not recruiting
      • Overweight and Obesity
      • +2 more
      • Silibinin A
      • Murcia, Spain
        Faculty of Nursing. Catholic University of Murcia
      May 17, 2022

      Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe

      Active, not recruiting
      • Hypercholesterolemia
      • Mixed Dyslipidemia
      • Bempedoic acid and/or its fixed-dose combination with ezetimibe
      • Aue, Germany
      • +126 more
      May 9, 2022

      Hyperlipidemias, Hypercholesterolemia Trial in Cheras (Placebo, 250 mg OPP)

      Completed
      • Hyperlipidemias
      • Hypercholesterolemia
      • Placebo
      • 250 mg OPP
      • Cheras, WP Kuala Lumpur, Malaysia
        National University of Malaysia
      Apr 5, 2022

      Hypercholesterolemia Trial in Beijing (IBI306 450mg SC Q4W, Placebo SC Q4W, IBI306 600mg SC Q6W)

      Completed
      • Hypercholesterolemia
      • IBI306 450mg SC Q4W
      • +3 more
      • Beijing, China
        Peking University First Hospital
      Apr 2, 2022

      Hypercholesterolemia Trial (pitavastatin, atorvastatin)

      Completed
      • Hypercholesterolemia
      • (no location specified)
      Apr 4, 2022

      Hypercholesterolemia in Children Using Dried Blood Spot

      Not yet recruiting
      • Hypercholesterolemia
      • blood test
      • Bron, France
      • +1 more
      Mar 25, 2022

      Hypercholesterolemia Trial in United States (ETC-1002, Placebo)

      Completed
      Has Results
      • Hypercholesterolemia
      • Hartford, Connecticut
      • +4 more
      Mar 10, 2022

      Hypercholesterolemia, Cardiovascular Risk Factor, Dyslipidemias Trial in France, Germany (TOTUM-070, Placebo)

      Completed
      • Hypercholesterolemia
      • +4 more
      • TOTUM-070
      • Placebo
      • Lille, France
      • +3 more
      Mar 28, 2022

      Hypercholesterolemia Trial in Worldwide (ALIROCUMAB SAR236553 (REGN727), (for injection training only), ezetimibe)

      Completed
      Has Results
      • Hypercholesterolemia
      • ALIROCUMAB SAR236553 (REGN727)
      • +5 more
      • Graz, Austria
      • +152 more
      Mar 21, 2022

      Guideline-driven Lifestyle Interventions, Including Use

      Recruiting
      • Hypercholesterolemia
        • Unterhautzenthal, Austria
        • +6 more
        Mar 4, 2022

        Hypercholesterolemia Trial in Changchun (DC371739 Tablets, Placebo)

        Completed
        • Hypercholesterolemia
        • DC371739 Tablets
        • Placebo
        • Changchun, Ji Lin, China
          The First Hospital of Jilin University
        Mar 15, 2022

        Hypercholesterolemia Trial in Adelaide (Swisse Nutra+ Cholesterol Balance, Placebo)

        Completed
        • Hypercholesterolemia
        • Swisse Nutra+ Cholesterol Balance
        • Placebo
        • Adelaide, South Australia, Australia
          CSIRO Nutrition and Health Research Clinic
        Mar 9, 2022

        Coronary Disease, Stroke, Chronic Kidney Disease Trial in Calgary (Copayment Elimination, Personalized Education)

        Completed
        • Coronary Disease
        • +6 more
        • Copayment Elimination
        • Personalized Education
        • Calgary, Alberta, Canada
          University of Calgary
        Mar 2, 2022

        Hypercholesterolemia, Hyperlipidemias, Physical Inactivity Trial in Adelaide (Egg diet, Egg-free Diet, Control Diet)

        Recruiting
        • Hypercholesterolemia
        • +3 more
        • Egg diet
        • +2 more
        • Adelaide, South Australia, Australia
          University of South Australia Clinical Trial Facility
        Mar 1, 2022

        Hypercholesterolemia Trial in Chuo-ku,Tokyo (180mg of ETC-1002(bempedoic acid), 120mg of ETC-1002(bempedoic acid), 60mg of

        Active, not recruiting
        • Hypercholesterolemia
        • 180mg of ETC-1002(bempedoic acid)
        • +3 more
        • Chuo-ku,Tokyo, Japan
          Tokyo-Eki Center-Building Clinic
        Mar 3, 2022